ReviewDer Pathologe2012
[Lymphomas and lymphatic leukemias in the bone marrow].
Review in Der Pathologe, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A bone marrow biopsy in a patient with a diagnosis of lymphoma is often performed as part of the staging procedures, i.e. to find out whether or not the bone marrow harbors infiltrates of an already diagnosed tumor. On the other hand, occasionally changes in the peripheral blood count or an M-protein in the serum lead to a bone marrow biopsy in which the first diagnosis of a malignant lymphoma is established. In either case, the diagnosis of lymphomas and lymphatic leukemias in the bone marrow requires an integration of clinical data, cytomorphology, the topographic distribution of the infiltrate and immunohistochemical as well as molecular techniques, where required. This may particularly be the case when confirmation or exclusion of conventionally barely detectable infiltrates (e.g. hairy cell leukemia, hepatosplenic T-cell lymphoma, plasma cell infiltrates) is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.